On ECHEMI
Home > Drugs > cholangitis
cholangitis
Biliary inflammation mainly characterized by inflammation of the bile duct is called cholangitis, and mainly characterized by inflammation of the gallbladder is called cholecystitis. The two often occur simultaneously, and their etiology, pathogenesis, and pathological changes are roughly the same. They are mostly caused by secondary bacterial infection (mainly Escherichia coli, paracolon, and Staphylococcus aureus, etc.) on the basis of bile stasis. Bacteria can reach the bile duct through the lymphatic or blood ducts, or they can enter the bile duct from the intestine through the duodenal papilla in a retrograde manner. The latter is more common in my country. It can be divided into two types: acute and chronic.
Related Drugs
Anti-inflammatory and choleretic tablets
Manufacturer:

Guangzhou Yuhua Pharmaceutical Co., Ltd.

Anti-inflammatory and choleretic tablets
Manufacturer:

Guangdong Luofushan Baihe Pharmaceutical Factory

Anti-inflammatory and choleretic tablets
Manufacturer:

Guangzhou Baiyunshan Huacheng Pharmaceutical Co., Ltd.

Cefuroxime Sodium
Indication: This product can be used to treat the following infections caused by the above-mentioned sensitive bacteria: 1. Respiratory system infections: tonsillitis, peritonsillar abscess, bronchitis, bronchiolitis, bronchiectasis (when infected), secondary infections of chronic respiratory diseases, pneumonia, pulmonary suppuration; 2. Urinary system infections: pyelonephritis, cystitis; 3. Abdominal infections: cholecystitis, cholangitis, peritonitis; 4. Pelvic infections: pelvic peritonitis, adnexitis, intrauterine infection, pelvic dead cavity inflammation, parametrial tissue inflammation; 5. Sepsis.
Manufacturer:

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Ursodeoxycholic acid capsules
Indication: For the treatment of: 1. Cholestatic liver disease, including chronic liver disease with intrahepatic cholestasis, primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC); 2. Cholesterol stones; 3. Chronic hepatitis C; 4. Bile reflux gastritis; 5. Rejection of allogeneic organ transplantation; 6. Biliary pancreatitis;
Anti-inflammatory and choleretic tablets
Manufacturer:

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Anti-inflammatory and choleretic tablets
Manufacturer:

Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.

Anti-inflammatory and choleretic tablets
Manufacturer:

Dalian Zhenao Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.